I agree that this site is using cookies. You can find further informations here.
X
Brosa, M.
~ 100  results:
Search for persons X
?
1

PIN154 QALY Losses Attributable to COVID-19 Pandemic in Spa..:

Hernando, V. ; Brosa, M.
Value in Health.  23 (2020)  - p. S569 , 2020
Link: https://doi.org/10.1016/..
 
?
2

PBI42 Biologic Treatments for Psoriasis: Cost of Alternativ..:

Costa-Samarra, J. ; Hurtado, P. ; Diana, N...
Value in Health.  23 (2020)  - p. S417 , 2020
Link: https://doi.org/10.1016/..
 
?
3

PNS270 Real World Evidence and Risk-sharing Agreements: Sha..:

Brosa, M. ; Avendaño-Solà, C. ; Espin, J...
Value in Health.  23 (2020)  - p. S686 , 2020
Link: https://doi.org/10.1016/..
 
?
4

A cost-utility analysis of increasing percutaneous coronary..:

Forné, C ; Subirana, I ; Blanch, J...
European Journal of Preventive Cardiology.  28 (2020)  4 - p. 408-417 , 2020
Link: https://doi.org/10.1177/..
 
?
5

PRO80 COMPARISON OF EARLY ACCESS PROGRAMMES FOR ORPHAN DRUG..:

Schleich, W. ; Vollmer, L. ; Prada, M....
Value in Health.  22 (2019)  - p. S855-S856 , 2019
Link: https://doi.org/10.1016/..
 
?
6

PMU66 TIMEFRAME FOR DRUG MARKETING AUTHORIZATION IN EUROPE:

Costa-Samarra, J. ; Cuesta, M. ; Brosa, M.
Value in Health.  22 (2019)  - p. S719 , 2019
Link: https://doi.org/10.1016/..
 
?
7

PCN144 ECONOMIC EVALUATIONS OF CANCER INTERVENTIONS IN SPAI..:

Pomares, E. ; Uría, E. ; Cuesta, M..
Value in Health.  22 (2019)  - p. S463 , 2019
Link: https://doi.org/10.1016/..
 
?
8

PMU52 ANALYSIS OF THE REIMBURSEMENT DECISIONS MADE BY THE I..:

Sánchez-Martín, J. ; Cuesta, M. ; Brosa, M.
Value in Health.  22 (2019)  - p. S717 , 2019
Link: https://doi.org/10.1016/..
 
?
9

1467Cost-effectiveness analysis of increased use of percuta..:

Roman Degano, I ; Forne, C ; Ferrieres, J...
European Heart Journal.  39 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
10

PSY165 - PRICE DIFFERENCES FOR ORPHAN DRUGS ACROSS THE EU-5..:

Brosa, M. ; Prada, M. ; Berard, I...
Value in Health.  21 (2018)  - p. S464 , 2018
Link: https://doi.org/10.1016/..
 
?
11

Economic Impact Of Severe Asthma In Spain: Observational Lo..:

Melero, C ; Quirce, S ; Huerta, A...
Value in Health.  20 (2017)  9 - p. A644 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Estimate of the total costs of allergic rhinitis in special..:

Colás, C. ; Brosa, M. ; Antón, E....
Allergy.  72 (2017)  6 - p. 959-966 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chro..:

Lacasa, C ; Obradors, M ; Figueras, M..
Value in Health.  19 (2016)  7 - p. A650 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Instrumentos Para la Incorporacion de la Evaluacion Economi..:

Brosa, M ; Puig-Junoy, J ; Gasol-Boncompte, M...
Value in Health.  18 (2015)  7 - p. A855 , 2015
Link: https://doi.org/10.1016/..
 
?
15

Efficiency of A Personalized Care Model In Diabetes As An E..:

López-Martínez, N ; Brosa, M ; Segú-Tolsà, L..
Value in Health.  18 (2015)  7 - p. A617 , 2015
Link: https://doi.org/10.1016/..
 
1-15